Citigroup Issues Pessimistic Forecast for Victrex (LON:VCT) Stock Price

Victrex (LON:VCT - Get Free Report) had its price objective cut by stock analysts at Citigroup from GBX 870 ($11.67) to GBX 740 ($9.93) in a research report issued on Friday, Marketbeat.com reports. The firm currently has a "neutral" rating on the stock. Citigroup's price objective suggests a potential upside of 5.87% from the company's current price.

Several other equities analysts have also recently commented on the stock. Deutsche Bank Aktiengesellschaft cut shares of Victrex to a "hold" rating and lowered their price target for the company from GBX 990 ($13.28) to GBX 850 ($11.40) in a report on Tuesday, July 8th. JPMorgan Chase & Co. lowered their price target on shares of Victrex from GBX 940 ($12.61) to GBX 818 ($10.97) and set a "neutral" rating on the stock in a report on Wednesday, July 9th.

Victrex Price Performance

Shares of LON VCT traded up GBX 1 ($0.01) during trading on Friday, hitting GBX 699 ($9.38). The company had a trading volume of 320,340 shares, compared to its average volume of 407,000. The company has a market cap of £609.75 million, a P/E ratio of 19.86, a PEG ratio of 1.92 and a beta of 0.69. Victrex has a 52 week low of GBX 667.62 ($8.96) and a 52 week high of GBX 1,160 ($15.56). The business's 50-day moving average is GBX 774.97 and its 200 day moving average is GBX 872.95. The company has a debt-to-equity ratio of 10.93, a quick ratio of 1.99 and a current ratio of 4.39.

Victrex (LON:VCT - Get Free Report) last announced its earnings results on Monday, May 12th. The company reported GBX 22.60 ($0.30) earnings per share (EPS) for the quarter. Victrex had a net margin of 10.81% and a return on equity of 6.67%. Equities research analysts predict that Victrex will post 73.1078905 earnings per share for the current fiscal year.

Insider Transactions at Victrex

In other Victrex news, insider Dame Vivienne Cox purchased 2,747 shares of the company's stock in a transaction that occurred on Tuesday, July 8th. The stock was purchased at an average price of GBX 721 ($9.67) per share, with a total value of £19,805.87 ($26,567.23). Also, insider David Thomas purchased 1,158 shares of the company's stock in a transaction that occurred on Tuesday, May 13th. The stock was acquired at an average cost of GBX 846 ($11.35) per share, with a total value of £9,796.68 ($13,141.09). 1.64% of the stock is currently owned by corporate insiders.

Victrex Company Profile

Victrex plc, through its subsidiaries, engages in the manufacture and sale of polymer solutions worldwide. The company operates through two segments, Sustainable Solutions and Medical. It develops PEEK and PAEK based polymer solutions, and semi-finished and finished parts. The company also provides specialist solutions for medical device manufacturers; sells thermoplastic polymers; sustainable solutions for energy and industrial, VAR, automotive, aerospace, and electronics markets; and engages in trading activities.